UrgoTul Ag is indicated for the treatment of wounds at risk of infection or showing signs of local infection: UrgoTul Absorb is indicated for all exuding chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers), acute wounds (2nd degree burns, skin abrasions, traumatic wounds, post-operative wounds….) and for the local treatment of fungating wounds in combination with a specific treatment. Ease of dressing removal. Hundred percent of the Urgotul ™‐dressed wounds were reported as ‘very easy’ to change versus 87% and 13% reported as ‘easy’ and ‘difficult’ to change respectively in the TG‐dressed wounds. Bernard FX et al. Effets d’un pansement lipidocolloïde sur la production de matrice extracellulaire. Journal des Plaies et Cicatrisations, 2007 (study conducted on Urgotul). Pharmaceuticals - R Pharmaceuticals - S Pharmaceuticals - T Pharmaceuticals - U Pharmaceuticals - V Pharmaceuticals - W Pharmaceuticals - X Pharmaceuticals - Y Pharmaceuticals - Z

Urgotul Absorb Foam Dressing - MedicalDressings Urgotul Absorb Foam Dressing - MedicalDressings

Meaume S. et al., Management of chronic wounds with an innovative absorbent wound dressing. J Wound Care, Vol 21, No 7; July 2012, 315-322.The mean age of the subjects was 44 years old (minimum: 23, maximum: 65). The mean overall size of the burns sustained was 12% TBSA, with a minimum of 2·5% and maximum of 14·5%. The average area dressed with Urgotul ™ and TG was 118 and 112 cm 2, respectively. To prevent any risk of delay in appropriate treatment, UrgoStart is contraindicated in cancerous wounds and in fistular wounds demonstrating deep abscess formation. Acute wounds (burns, dermal abrasions, traumatic wounds, postoperative wounds), chronic wounds (pressure ulcers, diabetic foot ulcers) at the granulation and epithelialisation stage.

UrgoTul - Urgo Healthcare Professionals

If required UrgoTul Absorb and UrgoTul Absorb Heel can be cut using sterile equipment to adjust the size of the dressing to fit the wound.Couches & Chairs Variable Height Couches 2-Section Couches 3-Section Couches Fixed Height Gynaecology Couches Podiatry Chair Phlebotomy Chairs In the event of clinical signs of local infection, the doctor may decide to continue treatment using an antibacterial dressing. Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies. Clinically proven to facilitate wound progress with reduced signs of local infection over neutral dressings (2) Bernard FX, et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J Wound Care. 2005;14(5):215-221

UrgoTul | Wound Care Handbook UrgoTul | Wound Care Handbook

Assessment of healing was performed by two blinded observers at each dressing change with weekly photographs taken for later planimetric assessment. Other Single Use Instruments Curettes Needle Holders Probes Stitch Cutters Skin Staple Removers Proctology More... UrgoTul is produced using Lipido-Colloid Technology, an exclusive patented innovation from Laboratoires Urgo. NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.

UrgoTul is a non-occlusive flexible and conformable dressing comprising of a polyester mesh impregnated with Technology Lipido-Colloid (TLC) healing matrix.